BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20659004)

  • 1. The potential of small chemical functional groups for directing the differentiation of kidney stem cells.
    Murray P; Vasilev K; Fuente Mora C; Ranghini E; Tensaout H; Rak-Raszewska A; Wilm B; Edgar D; Short RD; Kenny SE
    Biochem Soc Trans; 2010 Aug; 38(4):1062-6. PubMed ID: 20659004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical biology in stem cell research.
    Choi Y; Nam TG
    Arch Pharm Res; 2012 Feb; 35(2):281-97. PubMed ID: 22370782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering small molecules to control stem cell fate.
    Andrews PD
    Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenobiotic kidney organogenesis: a new avenue for renal transplantation.
    Yokoo T; Kawamura T
    J Nephrol; 2009; 22(3):312-7. PubMed ID: 19557707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells in nephrology: present status and future.
    Watorek E; Klinger M
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):45-50. PubMed ID: 16642256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells and kidney diseases.
    Abbattista MR; Schena FP
    Minerva Med; 2004 Oct; 95(5):411-8. PubMed ID: 15467516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules in stem cell self-renewal and differentiation.
    Schugar RC; Robbins PD; Deasy BM
    Gene Ther; 2008 Jan; 15(2):126-35. PubMed ID: 17989703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell approaches for the treatment of renal failure.
    Brodie JC; Humes HD
    Pharmacol Rev; 2005 Sep; 57(3):299-313. PubMed ID: 16109837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing stem cell differentiation into the hepatic lineage in vitro.
    Heng BC; Yu H; Yin Y; Lim SG; Cao T
    J Gastroenterol Hepatol; 2005 Jul; 20(7):975-87. PubMed ID: 15955203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology insight: Innovative options for end-stage renal disease--from kidney refurbishment to artificial kidney.
    Braam B; Verhaar MC; Blankestijn P; Boer WH; Joles JA
    Nat Clin Pract Nephrol; 2007 Oct; 3(10):564-72. PubMed ID: 17895933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of small molecule compounds inducing differentiation of stem cells].
    Li X; Shan L; Li WL; Zhang SD; Zhang WD
    Yao Xue Xue Bao; 2011 Feb; 46(2):121-6. PubMed ID: 21542280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cells: a great hope for a new era of medicine.
    Tutter AV; Baltus GA; Kadam S
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):169-75. PubMed ID: 16566287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecules for stem cells.
    Kochegarov A
    Expert Opin Ther Pat; 2009 Mar; 19(3):275-81. PubMed ID: 19441903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview and synopsis of techniques for directing stem cell differentiation in vitro.
    Heng BC; Cao T; Haider HK; Wang DZ; Sim EK; Ng SC
    Cell Tissue Res; 2004 Mar; 315(3):291-303. PubMed ID: 14758536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring human embryonic stem cells for neurodegenerative disease therapy.
    Sonntag KC; Sanchez-Pernaute R
    Curr Opin Investig Drugs; 2006 Jul; 7(7):614-8. PubMed ID: 16869113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative medicine of the kidney.
    Perin L; Da Sacco S; De Filippo RE
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):379-87. PubMed ID: 21145933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular therapy of kidney diseases.
    Imai N; Kaur T; Rosenberg ME; Gupta S
    Semin Dial; 2009; 22(6):629-35. PubMed ID: 20017833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can patient-specific stem cell therapy enhance renal repair?
    Razzaque MS
    Nephrol Dial Transplant; 2008 Jun; 23(6):1826-30. PubMed ID: 18310601
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
    Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
    J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.